With some of those programs, as we commercialize the budworm efforts, for example, on our patents, as we sell it we have to repay a certain amount of the money back to Canada. We can achieve a certain level of commercialization, then we pay more money back to Canada, which is good, which is the way it should be.
On February 26th, 2015. See this statement in context.